Balance Sheet UnitedHealth Group Inc.

Equities

UNH

US91324P1021

Managed Healthcare

Market Closed - Nyse Other stock markets 01:30:02 11/04/2026 am IST			5-day change	1st Jan Change
304.33 ^USD	-0.84%		+9.76%	-7.81%

09/04	Piper Sandler Adjusts Price Target on UnitedHealth to $399 From $390, Maintains Overweight Rating	MT
08/04	US stocks end mixed on signs of progress before Trump's Iran deadline	RE

c.AE818J19gcaejr_sd65SCZKkFmpelSzbTJZH6xsN5VM.WhdWr8w89vPR4dCjPZcXbcftfDAfxkS_NvF_vGlVvSZnLFS15TPl9enH6g

Published financial data: UNITEDHEALTH GROUP INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	23TCr	26TCr	29TCr	31TCr	35TCr
Total Interest And Dividend Income	232.4Cr	203Cr	381.3Cr	449.2Cr	428Cr
Gain (Loss) on Sale of Investments, Total (Rev)	-	-	28Cr	71Cr	-36Cr
Non-Insurance Activities Revenues	3.44TCr	3.74TCr	4.26TCr	5.02TCr	5.34TCr
Other Revenues, Total	2.46TCr	2.76TCr	3.41TCr	3.6TCr	3.8TCr
Total Revenues	29TCr	32TCr	37TCr	40TCr	45TCr
Policy Benefits	19TCr	21TCr	24TCr	26TCr	31TCr
Depreciation & Amortization - (IS) - (Collected)	310.3Cr	340Cr	397.2Cr	409.9Cr	436.1Cr
Selling General & Admin Expenses, Total	4.26TCr	4.78TCr	5.46TCr	5.3TCr	5.96TCr
Non-Insurance Activities Expenses	3.1TCr	3.37TCr	3.88TCr	4.67TCr	5.07TCr
Total Operating Expenses	26TCr	30TCr	34TCr	37TCr	43TCr
Operating Income	2.4TCr	2.84TCr	3.24TCr	3.23TCr	1.9TCr
Interest Expense, Total	-166Cr	-209.2Cr	-324.6Cr	-390.6Cr	-400.2Cr
EBT, Excl. Unusual Items	2.23TCr	2.63TCr	2.91TCr	2.84TCr	1.5TCr
Gain (Loss) on Sale of Assets	-	-	-	-831Cr	-26Cr
EBT, Incl. Unusual Items	2.23TCr	2.63TCr	2.91TCr	2.01TCr	1.47TCr
Income Tax Expense	457.8Cr	570.4Cr	596.8Cr	482.9Cr	189Cr
Earnings From Continuing Operations	1.77TCr	2.06TCr	2.31TCr	1.52TCr	1.28TCr
Net Income to Company	1.77TCr	2.06TCr	2.31TCr	1.52TCr	1.28TCr
Minority Interest	-45Cr	-52Cr	-76Cr	-84Cr	-75Cr
Net Income - (IS)	1.73TCr	2.01TCr	2.24TCr	1.44TCr	1.21TCr
Net Income to Common Incl Extra Items	1.73TCr	2.01TCr	2.24TCr	1.44TCr	1.21TCr
Net Income to Common Excl. Extra Items	1.73TCr	2.01TCr	2.24TCr	1.44TCr	1.21TCr
Per Share Items
Net EPS - Basic	18.33	21.47	24.12	15.64	13.28
Basic EPS - Continuing Operations	18.33	21.47	24.12	15.64	13.28
Basic Weighted Average Shares Outstanding	94Cr	94Cr	93Cr	92Cr	91Cr
Net EPS - Diluted	18.08	21.18	23.86	15.51	13.23
Diluted EPS - Continuing Operations	18.08	21.18	23.86	15.51	13.23
Diluted Weighted Average Shares Outstanding	96Cr	95Cr	94Cr	93Cr	91Cr
Normalized Basic EPS	14.31	17.02	18.78	18.35	9.47
Normalized Diluted EPS	14.12	16.78	18.58	18.19	9.44
Dividend Per Share	5.6	6.4	7.29	8.18	8.73
Payout Ratio	30.55	29.78	30.21	52.29	65.66
American Depositary Receipts Ratio (ADR)	0.01	0.01	0.01	0.01	0.01
Supplemental Items
EBITDA	2.62TCr	3.08TCr	3.51TCr	3.5TCr	2.16TCr
EBITA	2.52TCr	2.97TCr	3.4TCr	3.4TCr	2.07TCr
EBIT	2.4TCr	2.84TCr	3.24TCr	3.23TCr	1.9TCr
EBITDAR	2.74TCr	3.21TCr	3.65TCr	3.64TCr	2.32TCr
Total Revenues (As Reported)	29TCr	32TCr	37TCr	40TCr	45TCr
Effective Tax Rate - (Ratio)	20.52	21.65	20.5	24.06	12.86
Current Domestic Taxes	393.2Cr	569.7Cr	513.4Cr	386.9Cr	197.9Cr
Current Foreign Taxes	52Cr	68Cr	107.9Cr	125.6Cr	166.3Cr
Total Current Taxes	444.8Cr	637.7Cr	621.3Cr	512.5Cr	364.2Cr
Deferred Domestic Taxes	-	-	-	-	-137.6Cr
Deferred Foreign Taxes	-	-	-	-	-38Cr
Total Deferred Taxes	13Cr	-67Cr	-24Cr	-30Cr	-175.2Cr
Normalized Net Income	1.35TCr	1.59TCr	1.74TCr	1.69TCr	860.02Cr
Supplemental Operating Expense Items
Net Rental Expense, Total	120Cr	130Cr	140Cr	140Cr	160Cr
Imputed Operating Lease Interest Expense	34Cr	40Cr	58Cr	61Cr	64Cr
Imputed Operating Lease Depreciation	86Cr	90Cr	82Cr	79Cr	96Cr
Stock-Based Comp., SG&A Exp. (Total)	-	92Cr	105.9Cr	101.8Cr	97Cr
Stock-Based Comp., Other (Total)	80Cr	-	-	-	-
Total Stock-Based Compensation	80Cr	92Cr	105.9Cr	101.8Cr	97Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Total Other Investments	4.38TCr	4.67TCr	4.99TCr	5.41TCr	5.58TCr
Total investments	4.38TCr	4.67TCr	4.99TCr	5.41TCr	5.58TCr
Cash And Equivalents	2.14TCr	2.34TCr	2.54TCr	2.53TCr	2.44TCr
Other Receivables - (Insurance Template)	2.81TCr	3.04TCr	3.9TCr	4.85TCr	5.27TCr
Separate Account Assets	444.9Cr	408.7Cr	375.5Cr	-	-
Gross Property Plant And Equipment	924.9Cr	1.04TCr	1.07TCr	854Cr	846.1Cr
Accumulated Depreciation	-385.7Cr	-449.9Cr	-421Cr	-364.5Cr	-371.9Cr
Net Property Plant And Equipment	539.2Cr	592.3Cr	645.7Cr	489.5Cr	474.2Cr
Goodwill	7.58TCr	9.34TCr	10TCr	11TCr	11TCr
Other Intangibles, Total	1.36TCr	1.86TCr	2.02TCr	2.89TCr	2.65TCr
Other Current Assets, Total	532Cr	662.1Cr	608.4Cr	821.2Cr	974.6Cr
Other Long-Term Assets, Total	1.43TCr	1.66TCr	1.92TCr	2.17TCr	2.52TCr
Total Assets	21TCr	25TCr	27TCr	30TCr	31TCr
Liabilities
Accounts Payable, Total	2.46TCr	2.77TCr	3.2TCr	3.43TCr	3.8TCr
Insurance And Annuity Liabilities	-	-	-	-	-
Unpaid Claims	2.45TCr	2.91TCr	3.24TCr	3.42TCr	3.93TCr
Unearned Premiums	257.1Cr	307.5Cr	335.5Cr	331.7Cr	341.3Cr
Current Portion of Long-Term Debt	362Cr	231Cr	318.6Cr	324.5Cr	382Cr
Current Portion of Leases	87Cr	100Cr	103.8Cr	101.4Cr	105.2Cr
Short-Term Borrowings	-	80Cr	108.8Cr	130Cr	224.9Cr
Long-Term Debt	4.24TCr	5.45TCr	5.83TCr	7.24TCr	7.23TCr
Long-Term Leases	340.3Cr	383.3Cr	386Cr	387.5Cr	356.3Cr
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	2.21TCr	2.53TCr	2.6TCr	2.63TCr	2.7TCr
Deferred Tax Liability Non-Current	326.5Cr	276.9Cr	302.1Cr	362Cr	242.1Cr
Other Non Current Liabilities	838.4Cr	900.6Cr	1.06TCr	1.21TCr	1.47TCr
Total Liabilities	14TCr	16TCr	17TCr	20TCr	21TCr
Common Stock, Total	1Cr	90L	90L	90L	90L
Additional Paid In Capital	-	-	-	-	56Cr
Retained Earnings	7.71TCr	8.62TCr	9.58TCr	9.6TCr	9.56TCr
Comprehensive Income and Other	-538.4Cr	-839.3Cr	-702.7Cr	-338.7Cr	-206.1Cr
Total Common Equity	7.18TCr	7.78TCr	8.88TCr	9.27TCr	9.41TCr
Minority Interest	471.9Cr	857.5Cr	1.02TCr	993.3Cr	758.8Cr
Total Equity	7.65TCr	8.63TCr	9.89TCr	10TCr	10TCr
Total Liabilities And Equity	21TCr	25TCr	27TCr	30TCr	31TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	94Cr	93Cr	92Cr	91Cr	91Cr
ECS Total Common Shares Outstanding	94Cr	93Cr	92Cr	92Cr	91Cr
Book Value / Share	76.26	83.27	96.06	101.27	103.87
Tangible Book Value	-1.77TCr	-3.42TCr	-3.52TCr	-4.3TCr	-4.29TCr
Tangible Book Value Per Share	-18.76	-36.6	-38.06	-47	-47.33
Total Debt	5.03TCr	6.25TCr	6.74TCr	8.18TCr	8.3TCr
Net Debt	2.89TCr	3.91TCr	4.2TCr	5.65TCr	5.86TCr
Debt Equivalent Oper. Leases	960Cr	1.04TCr	1.12TCr	1.12TCr	1.28TCr
Minority Interest, Total (Incl. Fin. Div)	471.9Cr	857.5Cr	1.02TCr	993.3Cr	758.8Cr
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	50Cr	70Cr	71Cr	36Cr	39Cr
Buildings, Total	488.2Cr	551.9Cr	557.3Cr	421.5Cr	408.7Cr
Machinery, Total	386.5Cr	420.6Cr	438.2Cr	396.1Cr	398.7Cr
Full Time Employees	4L	4L	4L	4L	4L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.73TCr	2.01TCr	2.24TCr	1.44TCr	1.21TCr
Depreciation, Depletion & Amortization	98Cr	110Cr	117.2Cr	100Cr	96Cr
Amortization of Goodwill and Intangible Assets - (CF)	120Cr	130Cr	160Cr	170Cr	170Cr
Total Depreciation, Depletion & Amortization	218Cr	240Cr	277.2Cr	269.9Cr	266.1Cr
Amortization of Deferred Charges, Total	92Cr	100Cr	120Cr	140Cr	170Cr
(Gain) Loss On Sale of Asset - (CF)	-	-	-	497.7Cr	-64Cr
Stock-Based Compensation (CF)	80Cr	92Cr	105.9Cr	101.8Cr	97Cr
Change in Accounts Receivable	-100Cr	-252.3Cr	-311.4Cr	-143.7Cr	-76Cr
Change in Accounts Payable	116.2Cr	196.4Cr	351.6Cr	246.3Cr	166.5Cr
Change in Unearned Revenues	-31Cr	13Cr	20Cr	-20Cr	16Cr
Change in insurance Reserves / Liabilities	270.1Cr	405.3Cr	348.2Cr	250.3Cr	582.4Cr
Change in Other Net Operating Assets (Collected)	-103.1Cr	-137.4Cr	-244.4Cr	-414Cr	-460.6Cr
Other Operating Activities	-37Cr	-48Cr	1.3Cr	51Cr	67Cr
Cash from Operations	2.23TCr	2.62TCr	2.91TCr	2.42TCr	1.97TCr
Capital Expenditure	-245.4Cr	-280.2Cr	-338.6Cr	-349.9Cr	-362.2Cr
Sale of Property, Plant, and Equipment	-	341.4Cr	68Cr	204.1Cr	56Cr
Cash Acquisitions	-482.1Cr	-2.15TCr	-1.01TCr	-1.34TCr	-450.9Cr
Investment in Marketable and Equity Securities, Total	-184.3Cr	-683.7Cr	-177.7Cr	52Cr	36Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-451.9Cr	-113.5Cr
Other Investing Activities, Total	-125.4Cr	-79Cr	-96Cr	-166.7Cr	-34Cr
Cash from Investing	-1.04TCr	-2.85TCr	-1.56TCr	-2.05TCr	-868.5Cr
Short Term Debt Issued, Total	-	73Cr	1.1Cr	-	81Cr
Long-Term Debt Issued, Total	693.3Cr	1.48TCr	639.4Cr	1.78TCr	296.9Cr
Total Debt Issued	693.3Cr	1.56TCr	640.5Cr	1.78TCr	377.6Cr
Short Term Debt Repaid, Total	-130.2Cr	-	-	-15Cr	-
Long-Term Debt Repaid, Total	-315Cr	-301.5Cr	-212.5Cr	-300Cr	-305Cr
Total Debt Repaid	-445.2Cr	-301.5Cr	-212.5Cr	-315.1Cr	-305Cr
Issuance of Common Stock	135.5Cr	125.3Cr	135.3Cr	184.6Cr	83Cr
Repurchase of Common Stock	-500Cr	-700Cr	-800Cr	-900Cr	-554.5Cr
Common Dividends Paid	-528Cr	-599.1Cr	-676.1Cr	-753.3Cr	-791.6Cr
Common & Preferred Stock Dividends Paid	-528Cr	-599.1Cr	-676.1Cr	-753.3Cr	-791.6Cr
Other Financing Activities, Total	-101.1Cr	342.8Cr	-240.1Cr	-348.5Cr	26Cr
Cash from Financing	-745.5Cr	422.6Cr	-1.15TCr	-351.2Cr	-1.16TCr
Foreign Exchange Rate Adjustments	-6.2Cr	3.4Cr	9.7Cr	-6.1Cr	4Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-22Cr	-36Cr
Net Change in Cash	445.4Cr	199Cr	206.2Cr	-12Cr	-95Cr
Supplemental Items
Cash Interest Paid	165.3Cr	194.5Cr	303.5Cr	359.4Cr	403Cr
Cash Income Tax Paid (Refund)	396.6Cr	522.2Cr	607.8Cr	462Cr	371.4Cr
Net Debt Issued / Repaid	248.1Cr	1.25TCr	428Cr	1.47TCr	73Cr
Levered Free Cash Flow	1.84TCr	2.28TCr	1.98TCr	1.16TCr	1.39TCr
Unlevered Free Cash Flow	1.94TCr	2.41TCr	2.18TCr	1.4TCr	1.64TCr
Change In Net Working Capital	-298.8Cr	-477.5Cr	2.3Cr	778.2Cr	-280.2Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.32	7.76	7.79	7.06	3.9
Return on Total Capital	12.44	13.1	13.03	11.67	6.51
Return On Equity %	24.12	25.35	24.98	15.13	12.54
Return on Common Equity	25.19	26.91	26.88	15.88	12.91
Margin Analysis
Gross Profit Margin %	24.22	24.56	24.48	22.33	18.53
SG&A Margin	14.8	14.74	14.7	13.24	13.31
EBITDA Margin %	9.09	9.51	9.45	8.74	4.83
EBITA Margin %	8.75	9.17	9.14	8.49	4.62
EBIT Margin %	8.33	8.77	8.71	8.07	4.24
Income From Continuing Operations Margin %	6.17	6.37	6.23	3.81	2.86
Net Income Margin %	6.01	6.21	6.02	3.6	2.69
Net Avail. For Common Margin %	6.01	6.21	6.02	3.6	2.69
Normalized Net Income Margin	4.69	4.92	4.69	4.22	1.92
Levered Free Cash Flow Margin	6.39	7.02	5.33	2.89	3.1
Unlevered Free Cash Flow Margin	6.75	7.43	5.88	3.5	3.66
Asset Turnover
Asset Turnover	1.4	1.42	1.43	1.4	1.47
Fixed Assets Turnover	52.9	57.3	60.04	70.52	92.89
Receivables Turnover (Average Receivables)	19.42	18.6	17.31	16.66	18.06
Inventory Turnover (Average Inventory)	-	-	89.1	94.21	102.72
Short Term Liquidity
Current Ratio	0.73	0.73	0.75	0.83	0.79
Quick Ratio	0.66	0.65	0.69	0.75	0.7
Operating Cash Flow to Current Liabilities	0.29	0.29	0.29	0.23	0.17
Days Sales Outstanding (Average Receivables)	18.8	19.63	21.08	21.97	20.21
Days Outstanding Inventory (Average Inventory)	-	-	4.1	3.89	3.55
Average Days Payable Outstanding	78.29	79.03	78.96	77.99	73.14
Cash Conversion Cycle (Average Days)	-	-	-53.78	-52.14	-49.38
Long Term Solvency
Total Debt/Equity	65.74	72.33	68.17	79.73	81.62
Total Debt / Total Capital	39.66	41.97	40.54	44.36	44.94
LT Debt/Equity	59.87	67.57	62.8	74.31	74.62
Long-Term Debt / Total Capital	36.12	39.21	37.34	41.35	41.08
Total Liabilities / Total Assets	63.96	64.86	63.86	65.61	67.15
EBIT / Interest Expense	14.44	13.59	9.97	8.27	4.74
EBITDA / Interest Expense	16.48	15.36	11.25	9.32	5.8
(EBITDA - Capex) / Interest Expense	15	14.02	10.21	8.42	4.9
Total Debt / EBITDA	1.84	1.94	1.85	2.25	3.57
Net Debt / EBITDA	1.06	1.22	1.15	1.55	2.52
Total Debt / (EBITDA - Capex)	2.02	2.13	2.03	2.49	4.23
Net Debt / (EBITDA - Capex)	1.16	1.33	1.27	1.72	2.99
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.84	12.71	14.64	7.71	11.81
Gross Profit, 1 Yr. Growth %	3.96	14.31	14.24	-1.71	-7.25
EBITDA, 1 Yr. Growth %	6.81	17.81	13.93	-0.41	-38.19
EBITA, 1 Yr. Growth %	7.08	18.14	14.2	0.09	-39.2
EBIT, 1 Yr. Growth %	6.98	18.63	13.8	-0.22	-41.26
Earnings From Cont. Operations, 1 Yr. Growth %	12.45	16.39	12.14	-34.14	-15.98
Net Income, 1 Yr. Growth %	12.22	16.4	11.24	-35.64	-16.31
Normalized Net Income, 1 Yr. Growth %	7.14	18.14	9.32	-3.05	-49.11
Diluted EPS Before Extra, 1 Yr. Growth %	12.79	17.15	12.65	-35	-14.7
Net Property, Plant and Equip., 1 Yr. Growth %	-1.64	9.85	9.02	-24.19	-3.13
Inventory, 1 Yr. Growth %	-	-	-20	35.71	-13.16
Accounts Receivable, 1 Yr. Growth %	10.46	24.37	20.33	5.12	2.92
Total Assets, 1 Yr. Growth %	7.56	15.79	11.4	8.97	3.79
Common Equity, 1 Yr. Growth %	9.57	8.38	14.12	4.4	1.57
Tangible Book Value, 1 Yr. Growth %	-11.04	93.62	2.86	22.29	-0.28
Cash From Operations, 1 Yr. Growth %	0.76	17.29	10.92	-16.73	-18.62
Capital Expenditures, 1 Yr. Growth %	19.65	14.18	20.84	3.34	3.52
Levered Free Cash Flow, 1 Yr. Growth %	-8.21	18.24	-16.59	-44.5	10.13
Unlevered Free Cash Flow, 1 Yr. Growth %	-7.81	18.64	-12.85	-38.75	8.88
Dividend Per Share, 1 Yr. Growth %	15.94	14.29	13.91	12.21	6.72
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.98	12.28	13.67	11.12	9.74
Gross Profit, 2 Yr. CAGR %	9.97	9.01	14.28	5.97	-4.52
EBITDA, 2 Yr. CAGR %	9.82	12.2	15.85	6.52	-21.54
EBITA, 2 Yr. CAGR %	10.31	12.47	16.15	6.91	-21.99
EBIT, 2 Yr. CAGR %	10.35	12.66	16.19	6.56	-23.44
Earnings From Cont. Operations, 2 Yr. CAGR %	11.59	14.4	14.25	-14.06	-25.61
Net Income, 2 Yr. CAGR %	11.76	14.29	13.79	-15.39	-26.61
Normalized Net Income, 2 Yr. CAGR %	11.59	12.5	13.65	2.95	-29.76
Diluted EPS Before Extra, 2 Yr. CAGR %	12.32	14.95	14.88	-14.43	-25.54
Net Property, Plant and Equip., 2 Yr. CAGR %	-3.02	3.94	9.43	-9.09	-14.3
Inventory, 2 Yr. CAGR %	-	-	-	4.2	8.56
Accounts Receivable, 2 Yr. CAGR %	9.66	17.21	22.34	12.47	4.01
Total Assets, 2 Yr. CAGR %	10.47	11.6	13.57	10.18	6.35
Common Equity, 2 Yr. CAGR %	11.6	8.97	11.21	9.15	2.97
Tangible Book Value, 2 Yr. CAGR %	-9.09	31.25	41.12	12.16	10.43
Cash From Operations, 2 Yr. CAGR %	10.01	8.71	14.06	-3.9	-17.68
Capital Expenditures, 2 Yr. CAGR %	8.85	16.88	17.46	11.75	3.43
Levered Free Cash Flow, 2 Yr. CAGR %	8.96	6.62	1.46	-30.2	-18.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.33	6.9	3.77	-25.23	-15.44
Dividend Per Share, 2 Yr. CAGR %	16.3	15.11	14.1	13.05	9.43
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.33	10.21	13.06	11.65	11.35
Gross Profit, 3 Yr. CAGR %	8.96	11.4	10.73	8.68	1.36
EBITDA, 3 Yr. CAGR %	10.91	12.45	12.77	10.16	-11.15
EBITA, 3 Yr. CAGR %	11.33	12.86	13.05	10.53	-11.42
EBIT, 3 Yr. CAGR %	11.39	13.04	13.03	10.44	-12.63
Earnings From Cont. Operations, 3 Yr. CAGR %	12.72	13.17	13.64	-4.92	-14.71
Net Income, 3 Yr. CAGR %	12.98	13.29	13.26	-5.89	-15.69
Normalized Net Income, 3 Yr. CAGR %	12.15	13.73	11.43	7.79	-18.6
Diluted EPS Before Extra, 3 Yr. CAGR %	14.04	13.91	14.18	-4.98	-14.52
Net Property, Plant and Equip., 3 Yr. CAGR %	-2.17	1.09	5.61	-3.17	-7.14
Inventory, 3 Yr. CAGR %	-	-	-	-	-1.94
Accounts Receivable, 3 Yr. CAGR %	7.67	14.36	18.24	16.3	9.19
Total Assets, 3 Yr. CAGR %	11.71	12.21	11.53	12.02	8.01
Common Equity, 3 Yr. CAGR %	11.55	10.52	10.66	8.89	6.56
Tangible Book Value, 3 Yr. CAGR %	-2.82	16.97	21.01	34.54	7.85
Cash From Operations, 3 Yr. CAGR %	12.45	12.38	9.44	2.7	-9.08
Capital Expenditures, 3 Yr. CAGR %	5.96	10.6	18.19	12.55	8.93
Levered Free Cash Flow, 3 Yr. CAGR %	15.9	13.71	-0.35	-15.6	-16.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.26	13.31	1.22	-11.6	-13.25
Dividend Per Share, 3 Yr. CAGR %	17.52	15.63	14.71	13.46	10.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.24	10.01	10.43	10.57	11.72
Gross Profit, 5 Yr. CAGR %	9.93	11.11	11.05	9.19	4.36
EBITDA, 5 Yr. CAGR %	12.5	12.77	12.88	10.04	-2.46
EBITA, 5 Yr. CAGR %	12.75	13.05	13.23	10.44	-2.54
EBIT, 5 Yr. CAGR %	13.14	13.33	13.28	10.4	-3.28
Earnings From Cont. Operations, 5 Yr. CAGR %	20.18	13.78	13.33	1.37	-4.08
Net Income, 5 Yr. CAGR %	19.76	13.77	13.3	0.8	-4.78
Normalized Net Income, 5 Yr. CAGR %	12.9	13.41	12.74	9.29	-7.35
Diluted EPS Before Extra, 5 Yr. CAGR %	20.05	14.59	14.38	1.6	-3.77
Net Property, Plant and Equip., 5 Yr. CAGR %	6.85	5.1	2.32	-3.11	-2.86
Accounts Receivable, 5 Yr. CAGR %	11.76	13.07	13.32	13.6	12.33
Total Assets, 5 Yr. CAGR %	11.56	12.06	12.45	11.4	9.43
Common Equity, 5 Yr. CAGR %	13.4	10.24	11.42	9.97	7.52
Tangible Book Value, 5 Yr. CAGR %	-2.35	14.12	12.82	15.02	16.66
Cash From Operations, 5 Yr. CAGR %	17.93	14.02	13.09	5.56	-2.34
Capital Expenditures, 5 Yr. CAGR %	7.55	6.73	10.42	11.06	12.05
Levered Free Cash Flow, 5 Yr. CAGR %	9.99	11.06	10.91	-5.65	-7.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.95	11.11	11.49	-3.27	-4.92
Dividend Per Share, 5 Yr. CAGR %	18.71	17.36	16.14	14.59	12.57